Vitamin D Loading Dose in Advanced Lung Cancer
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Lung Cancer
Related studies linked through entity extraction aliases.
Imaging Study Compare 4DCT Image
- Status
- COMPLETED
- Phase
- PHASE1
Mithramycin for Lung, Esophagus, and Other Chest Cancers
- Status
- TERMINATED
- Phase
- PHASE2
A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Lung Cancer Diagnosis and Staging Using Ultrasound Guidance
- Status
- COMPLETED
- Phase
- N/A
Cisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Dysregulation of the C/EBPa Pathway in Human Lung Cancer and Search for New Biomarkers and/or Therapeutic Targets
- Status
- UNKNOWN
- Phase
- N/A
Tumor Specific Plasma DNA
- Status
- COMPLETED
- Phase
- N/A
Role of Activin A (ActA) in the Human Cancer Cachexia
- Status
- COMPLETED
- Phase
- NA
Prophylactic Cranial Irradiation in Patients With Lung Adenocarcinoma With High Risk of Brain Metastasis
- Status
- COMPLETED
- Phase
- NA
Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Cabozantinib in Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Self-Management Intervention for Breathlessness in Lung Cancer
- Status
- COMPLETED
- Phase
- NA
Radiomic Assessment in NSCLC: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Non-Invasive Biomarkers For Early Detection Of Lung Cancers
- Status
- COMPLETED
- Phase
- N/A
Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Tumor Markers in Lung Cancer: DCAMLK-1LK-1
- Status
- COMPLETED
- Phase
- NA
Chemotherapy Resistance and Sensitivity Testing in Lung Tumors
- Status
- COMPLETED
- Phase
- N/A